We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urinary Analysis in Early Pregnancy Predicts Likelihood of Preterm Birth

By LabMedica International staff writers
Posted on 24 Jul 2014
Print article
Analysis of metabolites in the urine during the early stages of pregnancy was found to be an effective approach for predicting the likelihood of a preterm birth.

Preterm birth (PB) and fetal growth restriction (FGR) convey high risk of infant mortality and morbidity, as well as increasing the chance of developing chronic disease in later life. Biomarkers identified early in pregnancy could predict poor birth outcomes and aid in their prevention and management.

Investigators at Imperial College London (United Kingdom) and the University of Crete (Greece) used proton nuclear magnetic resonance spectroscopy to analyze metabolites in urine samples obtained at the first ultrasound appointment from 438 pregnant women in the Rhea cohort. The Rhea cohort is a large population case-control mother-child study that started in Crete in 2007.

Results revealed that elevated urinary levels of lysine were associated with spontaneous premature birth. Decreased levels of acetate, formate, tyrosine, and trimethylamine were associated with poor fetal development. Women with decreased levels of these urine metabolites also showed signs of an increased risk of diabetes, such as higher blood insulin. Increased levels of an N-acetylated glycoprotein were significantly associated with induced preterm birth (IPB) in overweight and obese women only.

Senior author Dr. Hector Keun, senior lecturer in biological chemistry at Imperial College London, said, "While we know that metabolism in the mother changes substantially during pregnancy to help supply the growing fetus with nutrients, we were surprised to see so early in pregnancy a link between metabolites that we could easily detect in a urine sample and low birth weight. Our findings imply that it could be possible to improve the identification of women at higher risk of delivering smaller babies or premature delivery using noninvasive metabolic profiling technology early in pregnancy. Future investigation of the factors that produce the molecules associated with these pregnancy outcomes should improve our understanding of the genetic and environmental factors that influence restricted fetal growth and thus help us to reduce the likelihood of these events. We will also go on to test if exposure to these metabolites during pregnancy has a lasting impact on child development after birth."

The urine metabolites study was published in the July 11, 2014, online edition of the journal BMC Medicine.


Related Links:

Imperial College London

University of Crete



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.